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Abstract
Background: Although depression is a common problem in caregivers and there are effective cognitive-behavioral
interventions for its prevention, the ability of caregivers to attend these treatments is often limited by logistics.
Furthermore, the efficacy of the components of these interventions is unknown. The objectives of this study are to
(a) evaluate the efficacy of a telephone-administered cognitive-behavioral intervention to prevent depression with
all its components (cognitive and behavioral) and only with behavioral activation, and to (b) analyze the mediators
of the change in depressive symptoms.
Methods/Design: A randomized controlled clinical trial was designed to dismantle the components of a
cognitive-behavioral intervention. Caregivers with elevated depressive symptoms will be randomly assigned to a
cognitive-behavioral intervention, an intervention with only the behavioral activation component, or a usual care
control group. Each condition will consist of approximately 60 participants. The two interventions will consist of five
sessions lasting 90 min each, applied to groups of about 5 participants at a time via conference call. Trained
interviewers, blind to the experimental conditions, will conduct the assessments at the pre-treatment,
post-treatment and 1-, 3-, 6- and 12-month follow-ups.
Discussion: This study will provide evidence of the efficacy of a cognitive-behavioral intervention to prevent
depression in caregivers with elevated depressive symptoms administered via conference call, and on the impact of
the behavioral activation component on the overall efficacy of the program. If we find favorable results, it would
mean that we have developed a program of prevention of depression of higher clinical utility and efficacy than
those currently available, which would make it possible for a large number of caregivers to have access to such
resources.
Trial registration: ClinicalTrials.gov: NCT02292394. Registered 6 November 2014.
Keywords: Non-professional caregiver, Indicated prevention, Depression, Telephone intervention, Dismantling
strategy, Study protocol
* Correspondence: fernandolino.vazquez@usc.es
1Department of Clinical Psychology and Psychobiology, University of
Santiago de Compostela, Campus Vida, 15782 Santiago de Compostela,
Spain
Full list of author information is available at the end of the article
© 2015 Vázquez et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Vázquez et al. BMC Psychiatry  (2015) 15:300 
DOI 10.1186/s12888-015-0682-8
Background
Across the countries of the Organization for Economic
Co-operation and Development (OECD), more than one
in ten adults is involved in non-professional, typically un-
paid, caregiving, defined as providing help with personal
care or basic activities of daily living to people (family or
friends) with functional limitations [1]. However, caring
for a dependent family member involves emotional conse-
quences for caregivers [2], and can adversely affect their
mental health. In fact, it has been found that between
18 % and 48.3 % of caregivers have elevated depressive
symptoms [3, 4] and 8.9 % meet the criteria for a major
depressive episode [5].
Given their vulnerability, various programs of psycho-
logical intervention have been developed for caregivers
[6, 7], especially for those with depressive symptoms [8].
However, despite the evidence that having subclinical
depressive symptoms is a predictor of developing de-
pression [9], there are only two randomized controlled
trials [10, 11] aimed at preventing depression in care-
givers with high levels of symptoms that have not yet de-
veloped the disorder (i.e., indicated prevention [12]).
These interventions achieved a significant reduction in
depressive symptoms, but were applied face to face, and
face-to-face interventions, pose accessibility barriers to
caregivers. Many caregivers cannot participate in face-
to-face interventions due to difficulties such as time
constraints, lack of financial resources, lack of available
and geographically accessible support services, transpor-
tation problems, and problems finding a substitute care-
giver to the care for the familiar or stigmatization.
To overcome these barriers, communication technolo-
gies available to most people in their homes, such as the
telephone, can be used to implement the interventions.
There is evidence that psychotherapy via telephone for the
treatment of depressive symptoms is effective in reducing
depressive symptoms compared to control conditions
[13]. However, only two studies [14, 15] have evaluated
using telephone interventions to reduce depressive symp-
toms in the caregiver population. They were not indicated
prevention interventions for depression, and results re-
vealed that the interventions were partially efficacious in
reducing depressive symptoms. Davis and colleagues [14]
found no significant differences in depressive symptoms
between the face-to-face intervention conducted in home,
the phone intervention and the control group. Smith and
Toseland [15] only found decreased depressive symptoms
in a subsample of caregivers' children. Furthermore, the
small sample size, lack of long-term monitoring, the high
number of sessions (12 sessions) and interventions that
did not follow a theoretical model pose significant limita-
tions that may have contributed to restrict their results.
Moreover, the most effective interventions to reduce depres-
sive symptoms and prevent depression are multicomponent
cognitive-behavioral programs [8, 16]. Specifically, in an
indicated prevention intervention, Vázquez and colleagues
[11] applied cognitive techniques to change thought
patterns (e.g., double-standard technique, priming) and
behavioral techniques to active behaviors (e.g., pleasant ac-
tivities planning, reinforcement). They found a significant
reduction in the incidence of depression (1.1 % vs. 12.2 %)
and depressive symptoms (Cohen's d = 1.05) when com-
pared to the control group. Using a dismantling strategy
could help identify the contribution of behavioral activa-
tion techniques to the therapeutic change. As a result, this
can contribute to the improvement of the prevention pro-
gram and to greater efficiency. The behavioral activation
techniques should play an essential role because assuming
the caregiver role entails a number of behavioral changes
related to leisure and recreation, family life and work that
may involve a loss of positive reinforcement and an in-
crease in aversive experiences, factors relevant to the de-
velopment of depression [17]. In fact, a link between the
shortage of leisure activities for caregivers and depressive
symptoms has been previously demonstrated [18]. Fur-
thermore, previous research [19–22] comparing anti-
depressant medication, cognitive techniques aimed at the
automatic thoughts and underlying schemes, and behav-
ioral activation techniques have shown that behavioral in-
terventions are sufficient to effectively and efficiently treat
depression.
The objectives of the current study are to (a) evaluate
the efficacy of a complete cognitive-behavioral interven-
tion (including modification of negative and behavioral
activation techniques) and one consisting solely of
behavioral activation techniques, both of them adminis-
tered in a conference call to caregivers with high depres-
sive symptoms; and (b) analyze the mediators of change
in depressive symptoms. As the central hypothesis, we
expect both interventions to significantly reduce the in-
cidence of depressive episodes and symptoms compared
with the control group at post-treatment and at the 1-,
3-, 6- and 12-month follow-up. As secondary hypotheses
we expect that (a) the two interventions will differ in the
degree of improvement; (b) the change in automatic
negative thoughts, self-efficacy will mediate the effect of
the complete intervention and the increase in the




The current study will be a randomized controlled clinical
trial, wherein a dismantling design will be used. The dis-
mantling design consisted of analyzing the components of
a treatment package by removing one component of ther-
apy in one of the comparison groups [23]. Specifically,
three groups will be compared: (a) a cognitive-behavioral
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intervention via conference call (CBC) with cognitive and
behavioral techniques; (b) a behavioral activation interven-
tion via conference call (BAC) with only behavioral tech-
niques aimed at activating behavior; and (c) a control
group (CG) in which caregivers receive usual care.
The phases of the study are shown in Fig. 1. There will
be six measurement points in the three groups (i.e., pre-
treatment, post-treatment and 1-, 3-, 6- and 12-month
follow-ups). The first is baseline (pretreatment). Once the
caregivers who meet the eligibility criteria are selected and
we administer the interventions, we will conduct a post-
treatment evaluation and four subsequent follow-ups at 1,
3, 6, and 12 months. To minimize the loss of subjects, we
followed the strategies recommended by Grady and
colleagues [24] such as excluding those participants likely
to drop out; treat participants with kindness, affection and
respect or obtain several contact numbers to be able to
track the participant down in the future.
Sample size
Based on previous studies of indicated prevention of de-
pression in caregivers [10, 11, unpublished paper of Note
1] and studies that have administered therapies for de-
pression by phone (see [13]), we estimate that a sample
size of 56 participants per group (168 in total) will be
sufficient to detect a difference of 19 % in the rates of
incidence of depression episodes between experimental
and control conditions, assuming α = .05 and a power
(1 - β) of .80. However, assuming an attrition rate of 5-
8 %, we estimate that the sample size for each of the
groups should be approximately 60 subjects (180 in total).
Fig. 1 Flow diagram of the progress through the phases of the randomized controlled trial
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Participants, recruitment and eligibility criteria
Participants will be recruited from the Official Register
of Caregivers of the Ministry of Labor and Welfare of
the Galicia Regional Government in northwestern Spain.
A random sample of caregivers stratified by area type
[rural (<2000 inhabitants) or urban (≥2000 inhabitants)]
and province (Coruña, Lugo, Pontevedra or Orense) will
be selected. Previously we have determined that approxi-
mately 39 % and 44 % of caregivers have elevated
depressive symptoms [10, 11] and 8.9 % have depressive
episodes [5]. As a result, to achieve the estimated sample
size of approximately 180 participants we will need to
randomly select approximately 550 caregivers for a
screening prior to the verification of the eligibility
criteria.
Caregivers will be contacted by mail and invited to
participate in the study. They will be asked to return a
stamped postcard if they do not want to be contacted
further. Caregivers who do not return that card will be
contacted with a brief description of the study. Those
who are interested will undergo a screening to assess
depressive symptoms and history of depressive episodes.
Those who meet the initial selection criteria will be in-
vited to participate in a longer evaluation that will evalu-
ate the inclusion and exclusion criteria.
To be enrolled in the study, participants must meet
the following inclusion criteria: (a) be officially recog-
nized by the authorities as caregivers for a relative in a
situation of dependency, (b) have a telephone, (c) obtain
a pretreatment score ≥ 16 in the Center for Epidemio-
logic Studies Depression Scale (CES-D [25]), (d) not
meet the DSM-IV criteria for a major depressive episode
[26], (e) not have a history of major depression, (f ) give
informed consent. We will exclude those subjects that at
the time of the assessment: (a) have been receiving psy-
chological or pharmacological treatment for the last two
months, (b) experience other conditions that could act
as confounders in the study (e.g., symptoms due to the
direct physiological effects of a substance or a medical
condition), (c) have medical and mental disorders of
such severity that they require immediate intervention
(e.g., suicidal ideation) or that would make it impossible
to participate in the study (e.g., severe hearing impair-
ment), (d) care for a family member that has a terminal
diagnosis, (e) are planning to institutionalize the family
member or to move.
Randomization
Those subjects who meet the eligibility criteria and have
signed the informed consent forms will be randomly
assigned to the CBC, BAC or CG groups by an external
statistician using a table of random numbers. The scram-
bling sequence will be communicated to researchers
through numbered sealed envelopes, one for each partici-
pant, with instructions to use them in numerical order.
Interventions
The manuals for the intervention protocols will be devel-
oped during the first months of the project. Psychologists
who have been trained by two experienced clinicians, each
with over 20 years experience in cognitive-behavioral ther-
apies, will administer the interventions. Therapists will re-
ceive about 35 h of training consisting of theoretical and
practical seminars and role-playing exercises. They will
administer the interventions following the treatment man-
uals and will be monitored weekly. Each intervention will
be administered via conference call and will consist of five
90-min group sessions once a week. All sessions will be
recorded and the clinicians involved in the training of
therapists will use the recordings to assess adherence to
established protocols.
Cognitive-Behavioral Intervention via Conference Call (CBC)
CBC is an intervention based on the multifactorial inte-
grative model of depression by Lewinsohn and col-
leagues [17], which considers depression as the outcome
of behavioral, cognitive and emotional changes initiated
by the environment and moderated by cognitive factors.
The intervention will be adapted from a previous inter-
vention of indicated prevention of depression applied
face-to-face in a group format [11]. During the interven-
tion the participants will be trained in various cognitive
and behavioral skills such as self-monitoring of mood and
activity, relaxation techniques, self-reinforcement, increas-
ing pleasant activities, behavioral contracts, techniques
aimed at increasing positive thoughts and decreasing
depressogenic ones, training in assertive communication
and strategies to increase social contacts.
Behavioral Activation Intervention via Conference Call (BAC)
BAC will also be adapted from the program developed
by Vázquez and colleagues [11]. However, the interven-
tion will focus on the behavioral activation component
of the intervention. During the intervention the partici-
pants will be trained in different behavioral strategies
such as self-monitoring of mood and activity, self-
reinforcement, increasing pleasant activities, behavioral
contracts, and training in assertive communication and
in strategies to increase social interactions.
Usual Care Control Group (CG)
Usual care will constitute the control condition. People
assigned to this group will receive no intervention or
psychoeducational material. However, we will offer them
the possibility of accessing any medical or psychological
treatment (public or private) available in their commu-
nity to treat depressive symptoms.
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Outcomes
Throughout the study, we will collect information on
sociodemographic characteristics and situation of care,
major depressive episode and other mental disorders,
depressive symptoms, the mediating variables (negative
thoughts, self-efficacy, reinforcement, social contacts),
adherence to treatment, dropouts and satisfaction with
the interventions (see Table 1). The self-administered in-
struments will be mailed to participants to complete
them in their homes. The hetero-administered ones will
be administered via telephone by trained evaluators who
are unfamiliar with the purpose of the study, the inter-
ventions that will be administered and the random as-
signments into each group. Training of the evaluators will
consist of 15 h of theoretical and practical workshops and
role-playing on the instruments of measurement and evalu-
ation strategies by one of the study investigators who has
over 20 years experience in evaluation.
Socio-demographic and care situation characteristics
Through the Characteristics and Status of Caregiver
Questionnaire used in previous studies [10, 11] the
following information will be collected: sex, age, marital
status, social class, level of education, main occupation,
relative cared for, gender and age of the person receiving
care, duration (in years) of care and daily hours dedi-
cated to care.
Primary outcome measure: major depression
Major depression will be diagnosed with the help of the
Structured Clinical Interview for DSM-IV Axis I Disor-
ders, Clinician Version (SCID-CV) [27]. This is a semi-
structured interview providing DSM-IV diagnostics and
consists of six modules (mood episodes, psychotic symp-
toms, psychotic disorders, mood disorders, substance use
disorders, anxiety disorders, and other disorders). In the
initial assessment we will use the entire interview, whereas
only the major depressive episode module will be used in
the subsequent assessments. The SCID-CV has good test-
retest reliability and adequate reliability for psychiatric pa-
tients (kappa index = 0.61).
Secondary outcome measures
Depressive symptoms We will evaluate the severity of
the depressive symptoms using the self-reported scale
CES-D [25] (Spanish version of Vázquez and colleagues
[28]). This scale consists of 20 items in which the person
reports how often they experienced each symptom in the
last week by a Likert scale with 4 response options ranging
from 0 (rarely or none of the time) to 3 (most of the time).
The total score ranges from 0 to 60 and higher scores cor-
respond to greater depressive symptomatology. Its internal
consistency ranges from .85 to .90, with the Spanish ver-
sion having a score of .89.
Automatic negative thoughts The occurrence of auto-
matic negative thoughts will be evaluated with the Auto-
matic Thoughts Questionnaire (ATQ-N) [29], which has
been translated into Spanish by following the guidelines
of Guillemin and colleagues (using the translation /
back-translation method) [30]. This questionnaire con-
sists of 30 items in which the participant must indicate
the frequency with which they experienced the thoughts
during the last week on a Likert scale ranging from 1
(never) to 5 (always). The score ranges between 30 and
Table 1 Overview of measures
Instrument Intervention phase Format
Participant characteristics
Socio-demographic and care situation characteristics Pre-treatment Self-administered
Primary outcome
Major depression: SCID-CV Pre-treatment, Post-treatment,
1-, 3-, 6- and 12-month follow-ups
Hetero-administered
Secondary outcomes
Depressive symptoms: CES-D Pre-treatment, Post-treatment,
1-, 3-, 6- and 12-month follow-ups
Self-administered
Automatic negative thoughts: ATQ-N Pre-treatment, Post-treatment Self-administered
Reinforcement: EROS Pre-treatment, Post-treatment Self-administered
Register of social networking Pre-treatment, Post-treatment Self-administered
Self-efficacy: GSES Pre-treatment, Post-treatment Self-administered
Dropout and treatment adherence During the intervention, Post-treatment,
1-, 3-, 6- and 12-month follow-ups
Hetero-administered
Satisfaction with the service received: CSQ-8 Post-treatment Self-administered
Note: SCID-VC Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version, CES-D Center for Epidemiologic Studies Depression Scale, ATQ-N Automatic
Thoughts Questionnaire, EROS Environmental Reward Observation Scale, GSES General Self-Efficacy Scale, CSQ-8 Client Satisfaction Questionnaire
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150 with a higher score indicating more negative
thoughts. The internal consistency for the ATQ-N is .96.
Reinforcement We will use the self-administered Envir-
onmental Reward Observation Scale (EROS) [31] (Spanish
version of Barraca and Pérez-Álvarez [32]) to assess
reinforcement. It has 10 items in which the participant
evaluates the degree of positive reinforcement received
contingently from the subject’s environment on a Likert
scale ranging from 1 (strongly disagree) to 4 (strongly
agree). The total score ranges from 10 to 40, with a higher
score indicating a higher degree of positive reinforcement.
The internal consistency of the Spanish version is .86.
Social contacts The Register of Social Networking
(developed and used in the previous study by Vázquez
and colleagues [11]) will be used to assess the number of
participants' weekly social contacts. In this instrument
the participants are asked to report the number of
people they have had contact with daily.
Self-efficacy The self-administered General Self-Efficacy
Scale (GSES) [33] (Spanish version of Baessler and
Schwarzer [34]) will be used to evaluate the self-efficacy
of the caregivers. Through its 10 items, each participant
assesses the feeling of personal competence to handle
difficult situations on a Likert scale ranging from 1
(false) to 4 (true) with higher scores indicating greater
self-efficacy. The internal consistency of the Spanish ver-
sion is .81.
Dropout and treatment adherence We will construct a
registry of dropouts from each group over the duration
of the study. In addition, treatment adherence will be
assessed by recording the number of sessions each care-
giver attends and whether they complete homework
assignments.
Satisfaction with the service received We will evaluate
the participants' self-reported satisfaction with the
services received using the Client Satisfaction Question-
naire (CSQ-8) [35] (Castilian version of Vázquez and
colleagues [36]). It has 8 items with 4 possible answers
and a total score ranging from 8 to 32, with a higher
score indicating higher satisfaction. Its internal
consistency ranges between .83 and .93 [37].
Data management
Participant files are to be stored in numerical order and
stored in a secure and accessible place and manner.
Participant files will be maintained in storage for a
period of 5 years after completion of the study. All data
will be entered in a database; in which no individuals
can be identified. Range checks and consistency checks
against data already stored in the database will be made.
All forms, audios and hardware related to study data will
be kept in locked cabinets. Access to the study data will
be restricted. A password system will be utilized to con-
trol access. A complete back up of the primary database
will be performed twice a month. All reports will be pre-
pared such that no individual subject can be identified.
Statistical analyses
All analyzes will be conducted in accordance with the
principle of intention to treat. All participants will be
analyzed in the group to which they were assigned. The
most conservative approach for attrition will be adopted
by considering dropouts as a treatment failure (i.e., a
major depressive episode was triggered) and by replacing
missing data with the corresponding baseline scores. Cu-
mulative incidence rates of depression for all three
groups will be calculated to examine the efficacy of the
interventions on prevention of major depressive epi-
sodes. The relative risk (RR) and number needed to treat
(NNT) will be calculated according to the formulas pro-
posed by Guyatt et al. [38]. Also, the time it takes for
the participants to suffer a major depressive episode will
be analyzed using a survival analysis. The effect of the
interventions on depressive symptoms will be examined
by using mixed factorial analysis of variance (ANOVA)
tests with repeated measures. To examine the relation-
ship of the received interventions and depressive symp-
toms as mediated by change in automatic negative
thoughts, self-efficacy, and reinforcement, we will utilize
the method recommended by Baron and Kenny [39].
The acceptability and adherence to interventions will be
examined by using the Chi-Square test to compare the
percentages of dropouts and the Student t-test for inde-
pendent samples will be used to compare session attend-
ance and homework completion. The level of participant
satisfaction with the interventions will be analyzed with
frequency distribution of each item in the CSQ-8, and
we will compare results across both conditions using the
Student t-test for independent samples. All analyzes will
be conducted using SPSS for Windows, version 20.0.
Monitoring
A Data Monitoring Committee (DMC) will be established,
which is independent of the study organizers. Further-
more, the steering committee, led by the principal investi-
gator, will follow the principles of good clinical practice,
including the quality control of the clinical protocol and
data management and the organization of team meetings.
An annual report will be supplied, in strict confidence, to
the DMC about the trial development.
A pilot study will be conducted to assess the feasibility
of the protocol, interventions and instruments. Any
major modification to the protocol which may impact
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on the conduct of the study, potential benefit of the pa-
tient or may affect patient safety, including significant
changes of study design, patient population, sample sizes
or study procedures will require a formal amendment to
the protocol. Such amendment will be approved by the
Bioethics Committee prior to the implementation.
In addition, an interim-analysis will be performed after
the pilot study and on the primary end point when 50 %
of patients have been randomized and have completed
the follow-ups. The interim-analysis is performed by an
independent statistician. The statistician will report to
the independent DMC, who will have unblended access
to all data and will discuss the results of the interim-
analysis with the steering committee in a joint meeting.
The steering committee decides on the continuation of
the trial and will report to the Bioethics Committee.
Ethical issues
All human rights and the dignity of the subjects of the
study will be protected according to the Declaration of
Helsinki. All procedures in the study have been approved
by the Bioethics Committee of the University of Santiago
de Compostela (Spain). All participants will be guaranteed
confidentiality and will need to give informed consent
(first verbally by phone and then in written form using a
form that will be mailed to them). Participation in this
study will be completely voluntary and participants will
not receive any kind of incentive, financial or otherwise.
During the course of the study, if a caregiver develops
a major depressive episode, they will be removed from
the study and referred to mental health services available
in the community for treatment.
Discussion
In this study we will evaluate the efficacy of a brief
cognitive-behavioral intervention of indicated prevention
of depression and one consisting solely of behavioral acti-
vation techniques, both of them administered in a confer-
ence call to caregivers. The prevention programs applied
in this study were adapted from a previous study by
Vázquez and colleagues [11]. Based on their results, we
expect to find a significant reduction in the incidence of
depression and depressive symptoms in both intervention
groups when compared to a usual care control group.
The use of a conference call to administer psycho-
logical interventions as an alternative to traditional face-
to-face programs will increase the accessibility to mental
health services and increase the tools available to profes-
sionals to reach a larger number of people, following the
recommendations of National Institute of Mental Health
Psychosocial Intervention Development Workgroup [40]
and the New Freedom Commission on Mental Health
[41]. The advantages of interventions delivered through
via phone include anonymity, lower cost and increases
in accessibility [42]. Similarly to depression therapies ad-
ministered over the phone [13], we expect both inter-
ventions to significantly reduce depressive symptoms of
the caregivers and prevent the emergence of new de-
pressive episodes.
Moreover, the dismantling design of the current study
will allow the identification of the contribution of the
behavioral activation component to the efficacy of the
complete intervention program. This is a significant de-
velopment because until now no such analysis has been
conducted in any study aimed at caregivers. Similar to
the results found in clinical interventions for the treat-
ment of depression [20–22], it is expected that the inter-
vention of indicated prevention of depression with
techniques designed for behavioral activation will obtain
results similar to those of the full cognitive-behavioral
intervention. In the literature, behavioral activation has
been considered effective in treating depression in adults
[19], and it has been included as an evidence-based
treatment for depression in guidelines released by the
National Institute for Health and Clinical Excellence
[43]. If the effect of behavioral activation is powerful
enough, it would offer significant benefits to clinical
practice, such as achieving simpler effective interven-
tions for caregivers, which may be attractive to clinicians
as they are shorter and easier to learn and apply. In
addition, behavioral activation can be administered by
non-specialized personnel after brief training.
The strengths of this clinical trial include the specifica-
tion of the level of prevention and the selection of par-
ticipants accordingly, a priori sample size estimation,
randomized, controlled design with allocation conceal-
ment, implementation of an intervention based on a the-
oretical model of depression (which was efficacious in
previous clinical research) and applied using a manual,
evaluation of adherence to protocol, the evaluation of
the results by trained professionals who where blind to
the study conditions, and 12 months of follow-up. For
the evaluation of the outcome measures we will use vali-
dated instruments with sound psychometric properties
(see [44]). The incidence of depression as primary out-
come will be assessed with the SCID-CV, which has
been used as the gold standard for clinical diagnosis
[45]. Depressive symptoms as secondary outcomes will
be evaluated with the CES-D, which is the most widely
used tool to assess depressive symptoms in the popula-
tion of caregivers [46]. In addition, the study will be con-
ducted in the community context where the caregivers
live, resulting in a high level of generalizability.
In conclusion, this study can inform the understanding
of the efficacy of interventions to prevent depression in
caregivers and explore the use of alternative formats to
increase accessibility of therapies. It will also determine
if a simple intervention, with only behavioral techniques,
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is effective in preventing major depressive episodes. The
results of this study will benefit a large number of care-
givers in the present and the future, can be widely ap-
plied in health and social services.
Availability of data and materials
Investigators will communicate trial results via publica-
tions. The data supporting these findings will be pre-
sented in the main papers or can be obtained from the
authors upon request.
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